Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: A prospective, randomized, open label, single-center trial.

Phase I study of combination of antitumor immunotherapy targeted against cytomegalovirus (CMV) plus regulatory T-cell inhibition in patients with newly diagnosed glioblastoma multiforme (GBM). This is ...

(RTTNews) - Novocure (NVCR) announced the FDA approved new Head Flexible Electrode transducer arrays for use with Optune Gio for the treatment of adult patients with glioblastoma multiforme. Novocure ...

(RTTNews) - Novocure (NVCR) an oncology company, has received approval from the FDA for its new Head Flexible Electrode transducer arrays, designed for use with its Optune Gio device, which is used in ...

3 MHz Matrix Array Transducer – the M3dV 3 MHz Matrix Array features a new monolithic design that enhances image reconstruction and improves image quality; it utilizes 1024 elements in a 32 x 32 grid ...

The Vantage NXT system provides three encoder inputs that enable users to track position, movement, and rotation during data acquisition. Researchers can use encoder count data for Pulse-on-position ...

Emerson has released the Daniel™ T-200, a titanium-housed transducer, for its gas ultrasonic flow meter product line, marking the first use of metal 3D printing to enhance the acoustic performance of ...

ROOT, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved its new Head Flexible Electrode (HFE) transducer arrays for use ...